Trial Profile
A prospective, observational study evaluating safety of prasugrel in real-world patients with ST-segment elevation myocardial infarction (STEMI).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Aspirin; Clopidogrel; Vitamin K antagonists
- Indications Myocardial infarction
- Focus Adverse reactions
- Acronyms Bleed-MI
- 28 Feb 2017 New trial record